Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children

• Autors principals: Soon Min Lee (Autor), Sung Jin Kim (Autor), Jing Chen (Autor), Rok Song (Autor), Joon-Hyung Kim (Autor), Raghavendra Devadiga (Autor), Yun-Kyung Kim (Autor)
• Format: Llibre
• Publicat: Taylor & Francis Group, 2019-05-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including Korea. In accordance with Korean regulations, we conducted a post-marketing surveillance (PMS) to evaluate the safety of DTaP-IPV...